Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Growth Curve01:28

Bacterial Growth Curve

The bacterial growth curve is a fundamental concept in microbiology that describes the dynamics of bacterial population growth in a closed system with controlled environmental conditions, such as temperature and nutrient availability. This curve is divided into four distinct phases: lag, log (exponential), stationary, and death phases, each reflecting a unique stage of bacterial adaptation and growth. During the lag phase, bacteria acclimate to their surroundings by synthesizing essential...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Modeling with Differential Equations01:25

Modeling with Differential Equations

Population dynamics can be described mathematically by considering the population size P(t) as a function of time. The rate of change of the population is then represented by the derivative of P(t). A simple assumption is that the rate of growth is proportional to the size of the population itself. This leads to an exponential growth model, where the population increases rapidly without bound. While this is a useful first approximation, it does not reflect realistic long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantum pseudointegrable Hamiltonian impact system.

Physical review. E·2023
Same author

Bistable Bacterial Growth Dynamics in the Presence of Antimicrobial Agents.

Antibiotics (Basel, Switzerland)·2021
Same author

Non-Parametric Combined Reference Regions and Prediction of Clinical Risk.

Clinical chemistry·2020
Same author

Equilibration of energy in slow-fast systems.

Proceedings of the National Academy of Sciences of the United States of America·2017
Same author

Mechanistic modeling of hemoglobin glycation and red blood cell kinetics enables personalized diabetes monitoring.

Science translational medicine·2016
Same author

Leaky Fermi accelerators.

Physical review. E, Statistical, nonlinear, and soft matter physics·2015

Related Experiment Video

Updated: Jun 1, 2026

Time-lapse 3D Imaging of Phagocytosis by Mouse Macrophages
07:24

Time-lapse 3D Imaging of Phagocytosis by Mouse Macrophages

Published on: October 19, 2018

Bacteria-phagocyte dynamics, axiomatic modelling and mass-action kinetics.

Roy Malka1, Vered Rom-Kedar

  • 1Department of Computer Science and Applied Mathematics, The Weizmann Institute, Rehovot, Israel. roy.malka@weizmann.ac.il

Mathematical Biosciences and Engineering : MBE
|June 3, 2011
PubMed
Summary

A new axiomatic model describes bacterial growth and predator-prey dynamics, revealing crucial features missed by other models. This enhances understanding of infections in neutropenic conditions.

More Related Videos

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior
10:07

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior

Published on: January 31, 2020

Combining Fluidic Devices with Microscopy and Flow Cytometry to Study Microbial Transport in Porous Media Across Spatial Scales
12:32

Combining Fluidic Devices with Microscopy and Flow Cytometry to Study Microbial Transport in Porous Media Across Spatial Scales

Published on: November 25, 2020

Related Experiment Videos

Last Updated: Jun 1, 2026

Time-lapse 3D Imaging of Phagocytosis by Mouse Macrophages
07:24

Time-lapse 3D Imaging of Phagocytosis by Mouse Macrophages

Published on: October 19, 2018

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior
10:07

Generating Controlled, Dynamic Chemical Landscapes to Study Microbial Behavior

Published on: January 31, 2020

Combining Fluidic Devices with Microscopy and Flow Cytometry to Study Microbial Transport in Porous Media Across Spatial Scales
12:32

Combining Fluidic Devices with Microscopy and Flow Cytometry to Study Microbial Transport in Porous Media Across Spatial Scales

Published on: November 25, 2020

Area of Science:

  • Mathematical Biology
  • Ecology
  • Microbiology

Background:

  • Bacterial growth and predation are fundamental ecological processes.
  • Existing models may not fully capture complex dynamics like limited growth and predator saturation.
  • Understanding these dynamics is crucial for infectious disease research, particularly in immunocompromised states.

Purpose of the Study:

  • To develop a comprehensive axiomatic model for bacterial growth with phagocytes.
  • To classify bifurcation diagrams for these ecological models.
  • To investigate the impact of these dynamics on infections in neutropenic conditions.

Main Methods:

  • Axiomatic modeling approach.
  • Classification of bifurcation diagrams.
  • Integration with neutrophil dynamics models.

Main Results:

  • A family of models for bacterial growth and prey dynamics was established.
  • Key features of limited bacterial growth and phagocytosis saturation were identified at low concentrations.
  • New insights into infection development under neutropenia were gained by combining models.

Conclusions:

  • The proposed axiomatic models offer a more complete description of bacterial-phagocyte interactions.
  • Commonly used models may overlook significant ecological and physiological features.
  • This framework provides valuable insights for managing infections in neutropenic patients.